Actelion never made offer for ZS Pharma: CEO
Who wants to be a billionaire? Not Actelion's founder and CEO, if it means selling out | Fierce Pharma
Clozel's CHF1bn Actelion Spin-Out Idorsia Awaits Janssen Buy-In :: Scrip
Actelion's Fate May Rest on Structure, Not Price, as Clozel Holds Firm - TheStreet
Was plant das Ehepaar Clozel? | NZZ
Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (L) e Actelion CEO e fondatore Jean-Paul Clozel partecipano a una conferenza stampa presso la sede centrale di Actelion ad Allschwil, Svizzera, 26
Jean-Paul Clozel - CEO @ Idorsia - Crunchbase Person Profile
Actelion offers sweetener to stave off attacks - SWI swissinfo.ch
38 Jean Paul Clozel Photos and Premium High Res Pictures - Getty Images
Startup Guide on Twitter: "Jean-Paul and Martine Clozel are experienced founders and leading figures in the Basel Area. After Actelion, the first company they cofounded, was acquired by Johnson & Johnson, they
Actelion spinout Idorsia hits goals in insomnia phase 2, sparking stock rise and talk of partnering up for pivotal trial | Fierce Biotech
Martine et Jean-Paul Clozel, le couple vedette de la pharmacie mondiale
Big Boss - Jean-Paul Clozel, CEO Idorsia - Play RTS
J&J Makes Big Bet on Rare Disease With $30 Billion Actelion Deal - Bloomberg
Actelion - Wikipedia
Actelion Could Boost Takeover Price for Johnson & Johnson
J&J seals $30bn Swiss Actelion deal | The Peninsula Qatar
Jean-Paul Clozel, CEO Actelion - YouTube
Profile: Jean-Paul Clozel | Nature Biotechnology
Jean-Paul Clozel
